Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine

Journal of Virology

Volumn 83, Issue 17, 2009, Pages 8693-8704

  Van Der Sanden, Sabine ^a,b   Pallansch, Mark A ^c   Van De Kassteele, Jan ^a   El Sayed, Nasr ^d   Sutter, Roland W ^e   Koopmans, Marion ^a,b   Van Der Avoort, Harrie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MINISTRY OF HEALTH   (Egypt)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MONOVALENT TYPE 1 ORAL POLIOVIRUS VACCINE; ORAL POLIOMYELITIS VACCINE; PROTEIN VP3; UNCLASSIFIED DRUG; CAPSID PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VP1 PROTEIN, POLIOVIRUS;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRAIT; HUMAN; IMMUNOGENICITY; INOCULATION; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; PRIORITY JOURNAL; SEROCONVERSION; UNINDEXED SEQUENCE; VACCINATION; VIRUS CAPSID; VIRUS ISOLATION; VIRUS MUTATION; VIRUS SHEDDING; BLOOD; CLASSIFICATION; DNA SEQUENCE; EGYPT; GENETIC VARIABILITY; GENETICS; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MOLECULAR GENETICS; POLIOMYELITIS VIRUS;

HUMAN POLIOVIRUS 1; POLIOVIRUS;

AMINO ACID SUBSTITUTION; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; EGYPT; GENETIC VARIATION; HUMANS; INFANT; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEQUENCE ANALYSIS, DNA; VIRUS SHEDDING;

EID: 69249202547     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02388-08     Document Type: Article

References (43)

1. Agol, V. I. 2006. Vaccine-derived polioviruses. Biologicals 34:103-108.
2. Belnap, D. M., B. M. McDermott, Jr., D. J. Filman, N. Cheng, B. L. Trus, H. J. Zuccola, V. R. Racaniello, J. M. Hogle, and A. C. Steven. 2000. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc. Natl. Acad. Sci. USA 97:73-78.
3. Boot, H. J., J. Sonsma, F. van Nunen, F. Abbink, T. G. Kimman, and A. M. Buisman. 2007. Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people. Vaccine 25:4706-4714. (Pubitemid 46755455)
4. Cáceres, V. M., and R. W. Sutter. 2001. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin. Infect. Dis. 33:531-541.
5. CDC. 2007. Progress toward interruption of wild poliovirus transmission-worldwide, January 2006-May 2007. MMWR Morb. Mortal. Wkly. Rep. 56:682-685.
6. CDC. 2006. Progress toward poliomyelitis eradication - India, January 2005-June 2006. MMWR Morb. Mortal. Wkly. Rep. 57:772-776.
7. CDC. 2008. Progress toward poliomyelitis eradication - Nigeria, January 2007-August 12, 2008. MMWR Morb. Mortal. Wkly. Rep. 57:942-946.
8. CDC. 2006. Update on vaccine-derived polioviruses. MMWR Morb. Mortal. Wkly. Rep. 55:1093-1097.
9. CDC. 2007. Update on vaccine-derived polioviruses - worldwide, January 2006-August 2007. MMWR Morb. Mortal. Wkly. Rep. 56:996-1001.
10. Cherkasova, E. A., E. A. Korotkova, M. L. Yakovenko, O. E. Ivanova, T. P. Eremeeva, K. M. Chumakov, and V. I. Agol. 2002. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J. Virol. 76:6791-6799.
11. Chumakov, K. M., L. P. Norwood, M. L. Parker, E. M. Dragunsky, Y. X. Ran, and I. S. Levenbook. 1992. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J. Virol. 66:966-970.
12. Crainic, R., and O. Kew. 1993. Evolution and polymorphism of poliovirus genomes. Biologicals 21:379-384.
13. Dedepsidis, E., I. Karakasiliotis, et al. 2006. Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine. Virus Genes 33:183-191. (Pubitemid 44401424)
14. Dunn, G., N. T. Begg, N. Cammack, and P. D. Minor. 1990. Virus excretion and mutation by infants following primary vaccination with live oral polio vaccine from two sources. J. Med. Virol. 32:92-95.
15. el-Sayed, N., Y. el-Gamal, A. A. Abbassy, I. Seoud, M. Salama, A. Kandeel, E. Hossny, A. Shawky, H. A. Hussein, M. A. Pallansch, H. G. van der Avoort, A. H. Burton, M. Sreevatsava, P. Malankar, M. H. Wahdan, and R. W. Sutter. 2008. Monovalent type 1 oral poliovirus vaccine in newborns. N. Engl. J. Med. 359:1655-1665.
16. Fine, P. E., R. W. Sutter, and W. A. Orenstein. 2001. Stopping a polio outbreak in the post-eradication era. Dev. Biol. (Basel) 105:129-147.
17. Fricks, C. E., J. P. Icenogle, and J. M. Hogle. 1985. Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J. Virol. 54:856-859.
18. Gavrilin, G. V., E. A. Cherkasova, G. Y. Lipskaya, O. M. Kew, and V. I. Agol. 2000. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J. Virol. 74:7381-7390.
19. Georgescu, M. M., J. Balanant, A. Macadam, D. Otelea, M. Combiescu, A. A. Combiescu, R. Crainic, and F. Delpeyroux. 1997. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 71:7758-7768.
20. Grassly, N. C., J. Wenger, S. Durrani, S. Bahl, J. M. Deshpande, R. W. Sutter, D. L. Heymann, and R. B. Aylward. 2007. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 369:1356-1362. (Pubitemid 46613904)
21. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
22. He, Y., V. D. Bowman, et al. 2000. Interaction of the poliovirus receptor with poliovirus. Proc. Natl. Acad. Sci. USA 97:79-84.
23. He, Y., S. Mueller, P. R. Chipman, C. M. Bator, X. Peng, V. D. Bowman, S. Mukhopadhyay, E. Wimmer, R. J. Kuhn, and M. G. Rossmann. 2003. Complexes of poliovirus serotypes with their common cellular receptor, CD155. J. Virol. 77:4827-4835. (Pubitemid 36402832)
24. Icenogle, J. P., P. D. Minor, M. Ferguson, and J. M. Hogle. 1986. Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J. Virol. 60:297-301.
25. Jorba, J., R. Campagnoli, L. De, and O. Kew. 2008. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J. Virol. 82:4429-4440. (Pubitemid 351563679)
26. Kew, O., V. Morris-Glasgow, M. Landaverde, C. Burns, J. Shaw, Z. Garib, J. Andre, E. Blackman, C. J. Freeman, J. Jorba, R. Sutter, G. Tambini, L. Venczel, C. Pedreira, F. Laender, H. Shimizu, T. Yoneyama, T. Miyamura, H. van der Avoort, M. S. Oberste, D. Kilpatrick, S. Cochi, M. Pallansch, and C. de Quadros. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356-359. (Pubitemid 34303692)
27. Kew, O. M., R. W. Sutter, E. M. de Gourville, W. R. Dowdle, and M. A. Pallansch. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635.
28. Kew, O. M., R. W. Sutter, B. K. Nottay, M. J. McDonough, D. R. Prevots, L. Quick, and M. A. Pallansch. 1998. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J. Clin. Microbiol. 36: 2893-2899.
29. Laassri, M., E. Dragunsky, J. Enterline, T. Eremeeva, O. Ivanova, K. Lottenbach, R. Belshe, and K. Chumakov. 2005. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J. Clin. Microbiol. 43: 2886-2894.
30. Lentz, K. N., A. D. Smith, S. C. Geisler, S. Cox, P. Buontempo, A. Skelton, J. DeMartino, E. Rozhon, J. Schwartz, V. Girijavallabhan, J. O'Connell, and E. Arnold. 1997. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure 5:961-978.
31. Liu, H. M., D. P. Zheng, L. B. Zhang, M. S. Oberste, M. A. Pallansch, and O. M. Kew. 2000. Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J. Virol. 74:11153-11161.
32. Macadam, A. J., S. R. Pollard, G. Ferguson, R. Skuce, D. Wood, J. W. Almond, and P. D. Minor. 1993. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192:18-26. (Pubitemid 23213222)
33. Manor, Y., R. Handsher, T. Halmut, M. Neuman, A. Bobrov, H. Rudich, A. Vonsover, L. Shulman, O. Kew, and E. Mendelson. 1999. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian Authority. J. Clin. Microbiol. 37:1670-1675.
34. Martín, J., K. Odoom, G. Tuite, G. Dunn, N. Hopewell, G. Cooper, C. Fitzharris, K. Butler, W. W. Hall, and P. D. Minor. 2004. Long-term excretion of vaccine-derived poliovirus by a healthy child. J. Virol. 78:13839-13847. (Pubitemid 39612781)
35. Modlin, J. F. 1995. Poliomyelitis and poliovirus immunization, p. 195-220. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, DC.
36. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
37. Rozas, J., and R. Rozas. 1999. DnaSP, version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 15:174-175. (Pubitemid 29134733)
38. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. ClustalW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
39. van der Avoort, H. G., B. P. Hull, T. Hovi, M. A. Pallansch, O. M. Kew, R. Crainic, D. J. Wood, M. N. Mulders, and A. M. van Loon. 1995. Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 33:2562-2566.
40. WHO. 2004. Polio laboratory manual, 4th ed., p. 101-108. WHO, Geneva, Switzerland.
41. WHO. 2004. Polio laboratory manual, 4th ed., p. 88-91. WHO, Geneva, Switzerland.
42. Yakovenko, M. L., E. A. Cherkasova, G. V. Rezapkin, O. E. Ivanova, A. P. Ivanov, T. P. Eremeeva, O. Y. Baykova, K. M. Chumakov, and V. I. Agol. 2006. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J. Virol. 80:2641-2653.
43. Yang, C. F., L. De, B. P. Holloway, M. A. Pallansch, and O. M. Kew. 1991. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 20:159-179.